glp-1 oral medication for weight loss weight-loss drugs may also curb alcohol cravings Clinically backed oral GLP Weight loss pills may soon

A comprehensive literature search was performed in PubMed, Web of Science, Embase, and Scopus from inception to October 2025 using the keywords tirzepatide, GLP-1/GIP receptor agonist, obstructive sleep apnea, and obesity. Priority was given to randomized controlled trials, major observational studies, and relevant mechanistic research

Adjustment of any medication, for any reason, must be individualized by a practitioner with knowledge of the patient and their history, Brody says

For complete dosing details, see the tirzepatide dosing guide

At the starting dose, it lasts only two weeks, which is less than ideal

ACS Med